What is Gain Therapeutics, Inc. Common Stock's Market Cap?

Gain Therapeutics, Inc. Common Stock's Market Cap is $75.1M, based on as-reported figures from SEC (XBRL) filings.

What is Gain Therapeutics, Inc. Common Stock's Enterprise Value?

Gain Therapeutics, Inc. Common Stock's Enterprise Value is $62.3M, based on as-reported figures from SEC (XBRL) filings.

What is Gain Therapeutics, Inc. Common Stock's EV / EBITDA?

Gain Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Gain Therapeutics, Inc. Common Stock's Net Income (TTM)?

Gain Therapeutics, Inc. Common Stock's Net Income (TTM) is -$20.1M, based on as-reported figures from SEC (XBRL) filings.

What is Gain Therapeutics, Inc. Common Stock's EBITDA?

Gain Therapeutics, Inc. Common Stock's EBITDA is -$19.2M, based on as-reported figures from SEC (XBRL) filings.

What is Gain Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Gain Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.46, based on as-reported figures from SEC (XBRL) filings.

What is Gain Therapeutics, Inc. Common Stock's Net Debt?

Gain Therapeutics, Inc. Common Stock's Net Debt is -$12.7M, based on as-reported figures from SEC (XBRL) filings.

Gain Therapeutics, Inc. Common Stock (GANX) Financial Statements

Gain Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00W7D7CK7

XNAS · usd

1.72▼ 0.11 (-6.01%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.83

Day's Range1.72 – 1.83

52-Week Range1.53 – 4.34

Volume510.3K

Avg Volume448.5K

Share Statistics

Shares Outstanding

Employees21

ExchangeXNAS

Listed2021-03-18

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Gain Therapeutics, Inc. Common Stock (GANX)

What is Gain Therapeutics, Inc. Common Stock's Market Cap?: Gain Therapeutics, Inc. Common Stock's Market Cap is $75.1M, based on as-reported figures from SEC (XBRL) filings.
What is Gain Therapeutics, Inc. Common Stock's Enterprise Value?: Gain Therapeutics, Inc. Common Stock's Enterprise Value is $62.3M, based on as-reported figures from SEC (XBRL) filings.
What is Gain Therapeutics, Inc. Common Stock's EV / EBITDA?: Gain Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Gain Therapeutics, Inc. Common Stock's Net Income (TTM)?: Gain Therapeutics, Inc. Common Stock's Net Income (TTM) is -$20.1M, based on as-reported figures from SEC (XBRL) filings.
What is Gain Therapeutics, Inc. Common Stock's EBITDA?: Gain Therapeutics, Inc. Common Stock's EBITDA is -$19.2M, based on as-reported figures from SEC (XBRL) filings.
What is Gain Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Gain Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.46, based on as-reported figures from SEC (XBRL) filings.
What is Gain Therapeutics, Inc. Common Stock's Net Debt?: Gain Therapeutics, Inc. Common Stock's Net Debt is -$12.7M, based on as-reported figures from SEC (XBRL) filings.